CAUTIONDaily Alcohol Counteracts Core Stack GoalsTier 1
Daily 6 oz red wine (~1.5 standard drinks) activates PARP1 and the ALDH pathway, directly consuming NAD+ — the molecule NMN is specifically intended to restore. Simultaneously, ethanol suppresses collagen synthesis, increases renal magnesium excretion (compounding losses from caffeine), depletes B vitamins and zinc, and impairs hepatic vitamin D hydroxylation. This creates a pharmacological contradiction at the center of the stack: multiple supplements are being partially undermined by a daily dietary habit.
RecommendationConsider reducing to 3–4 glasses per week or less to allow NMN's NAD+-raising effect, magnesium repletion, and collagen synthesis to operate without daily alcohol-mediated antagonism.
Compounds: Red wine · NMN (Nicotinamide Mononucleotide) · Magnesium glycinate · Collagen peptides · Vitamin D3+K2
Vitamin D3 Dose Exceeds NIH Tolerable Upper Intake LevelTier 2
5000 IU/day of vitamin D3 exceeds the NIH ODS Tolerable Upper Intake Level of 4000 IU/day for adults. While hypercalcemia at this dose is uncommon without pre-existing baseline elevation, chronic doses above the UL can elevate serum calcium, suppress PTH, and strain renal calcium handling — risks that compound over time without monitoring. For a perimenopausal woman, this is the most important supplement to dose-confirm with a current serum 25(OH)D level.
RecommendationOrder a 25(OH)D, serum calcium, and PTH panel before continuing at 5000 IU; consider stepping down to 2000–3000 IU if baseline 25(OH)D is already ≥40 ng/mL.
Compounds: Vitamin D3+K2
Cumulative Caffeine Load from Coffee + Matcha Within 2 HoursTier 1
Black coffee at 9 AM (~95 mg caffeine) followed by matcha at 11 AM (~60–70 mg caffeine) delivers approximately 155–165 mg within a 2-hour window. This stacks two caffeine sources on top of shared adenosine receptor blockade and adds compounding urinary magnesium excretion — potentially offsetting the 300 mg magnesium glycinate dose taken in the evening. For a perimenopausal woman, caffeine sensitivity and cortisol reactivity are often heightened.
RecommendationMonitor for afternoon energy crashes, sleep-onset difficulty, or palpitations; if present, widen the coffee-to-matcha gap to 3+ hours or reduce matcha dose to 1g.
Compounds: Coffee black · Matcha Latte with Almond Milk · Magnesium glycinate
Unverified Human Safety Profile for BPC-157 and TB-500Tier 0
Both BPC-157 (250 mcg/day) and TB-500 (2.5 mg 2x/week) have robust animal-model data for tissue repair and angiogenesis, but neither compound has completed peer-reviewed Phase II/III human clinical trials establishing pharmacokinetics, dosing, or long-term safety in humans. The lack of human data means adverse effect profiles, particularly for angiogenic compounds in perimenopausal women, are unknown. These are being used outside established human pharmacology.
RecommendationMonitor CRP, liver function, and CBC at the end of each cycle (4–6 weeks for BPC-157, 4–8 weeks for TB-500); discuss use with a physician familiar with peptide pharmacology before continuing.
Compounds: BPC-157 (longevity) · TB-500 (Thymosin Beta-4)
Additive Antiplatelet Effect: Resveratrol + Omega-3 + Daily AlcoholTier 1
Resveratrol at 500 mg/day inhibits platelet aggregation via COX-1 and thromboxane A2 pathways; omega-3 at 2g/day adds further antiplatelet activity via eicosanoid modulation; daily alcohol adds a third antiplatelet layer. This triple combination produces a cumulative mild anticoagulant effect. While individually modest, together they meaningfully extend bleeding time — relevant ahead of surgery, dental procedures, or injury.
RecommendationDisclose this combination to any clinician or dentist before procedures; consider pausing resveratrol 5–7 days before elective surgery.
Compounds: Resveratrol (longevity) · Omega-3 · Red wine